TP53 and neuroendocrine carcinoma: Primary neuroendocrine carcinomas feature undifferentiated tumor cells characterized by severe gene alterations (e.g., biallelic inactivation of RB1 and TP53) responsible for de novo pathogenetic mechanisms.